Lucas Ting is an accomplished engineering leader with a robust background in the design and development of diagnostic medical devices. As the Director of Research & Development at Stasys Medical, Lucas leverages his extensive hands-on engineering experience to drive innovation in point-of-care solutions. His current...
Lucas Ting is an accomplished engineering leader with a robust background in the design and development of diagnostic medical devices. As the Director of Research & Development at Stasys Medical, Lucas leverages his extensive hands-on engineering experience to drive innovation in point-of-care solutions. His current focus is on the development of an automated electronic reader paired with disposable MEMS components, a project rooted in his Ph.D. research. This endeavor not only exemplifies his expertise in microfluidics and fluid mechanics but also highlights his commitment to advancing healthcare technology.
In his role, Lucas leads both system-level and sub-system-level design, ensuring seamless integration of complex interfaces. He is adept at designing mechanical structures, conducting geometric dimensioning and tolerance stack-up analyses, and performing cost and fault tree analyses to optimize manufacturability. His proficiency in finite element analysis (FEA) and simulations allows him to anticipate potential challenges and innovate solutions that enhance product reliability and performance.
Lucas's skill set extends beyond engineering design; he is also deeply involved in proprietary software development and manufacturing analysis, which are critical for the successful commercialization of medical devices. His hands-on approach in clinical trials and rigorous testing protocols ensures that Stasys Medical's products meet the highest standards of safety and efficacy. As a thought leader in the medical device industry, Lucas Ting is dedicated to transforming healthcare through cutting-edge technology and collaborative research, positioning Stasys Medical at the forefront of diagnostic innovation.